Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Tyrosine Kinase Inhibitors × Clear all

NCT02949843 2024-06-28

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Phase 2 Terminated

19 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung